权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Structure and function of the 5HT2A-mGlu2 heteromer in schizophrenia

5HT2A-mGlu2 异聚体在精神分裂症中的结构和功能

基本信息

批准号：
8813306
负责人：
Javier González-Maeso
金额：
$ 36.86万
依托单位：
VIRGINIA COMMONWEALTH UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-07-20 至 2019-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8813306
关键词：
Affect Affinity Agonist Animal Model Antipsychotic Agents Attention Attenuated Autopsy Behavior Behavioral Binding Biological Assay Brain Cells Chronic Clozapine Complex Confocal Microscopy Coupled Coupling Data Development Electron Microscopy Epigenetic Process Family Flow Cytometry Foundations Functional disorder G-Protein-Coupled Receptors GTP-Binding Proteins Geographic Locations Glutamates Goals HTR2A gene Histone Acetylation Histone Deacetylase Inhibitor Human Image In Vitro Knock-out Lead Ligand Binding Ligands Link Mediating Mental disorders Molecular Molecular Mechanisms of Action Mus Mutation Neurotransmitter Receptor Neurotransmitters Pathway interactions Pattern Pharmaceutical Preparations Population Prevalence Prevention Process Psychotic Disorders Receptor Signaling Risperidone Rodent Role Route Schizophrenia Sensory Receptors Serotonin Signal Transduction Simplexvirus Structure System Therapeutic Up-Regulation Virus Vorinostat Work atypical antipsychotic base behavioral response chromatin immunoprecipitation drug development frontal lobe hippocampal pyramidal neuron histone deacetylase 2 histone modification human CCR10 protein improved interdisciplinary approach metabotropic glutamate receptor 2 olanzapine pre-clinical prevent promoter protein activation public health relevance receptor response trafficking

项目摘要

DESCRIPTION (provided by applicant): Our final goal is to mechanistically characterize the essential role of the serotonin 5-HT2A (5HT2A) receptor and the metabotropic glutamate 2 (mGlu2) receptor as a G protein-coupled receptor (GPCR) heteromeric complex in regulating receptor trafficking, signaling, and antipsychotic-like behavior. The neurotransmitters serotonin and glutamate both have been the target of considerable attention regarding psychosis and antipsychotic drug development. Family A 5HT2A and family C mGlu2 are GPCRs that have been implicated in the pathophysiology and treatment of schizophrenia and other psychotic disorders. Atypical antipsychotic drugs, such as clozapine, olanzapine and risperidone, all have in common a high affinity for the 5HT2A receptor. Recent preclinical assays in rodents suggest that drugs that activate the mGlu2 receptor represent potential new antipsychotic medications. Our previous findings demonstrate that 5HT2A and mGlu2 maintain close molecular proximity in heterologous systems and in mouse frontal cortex. Using the combination of interdisciplinary approaches in vitro, in animal models and in postmortem human brain of schizophrenic subjects, we provide evidence that the 5HT2A-mGlu2 heteromeric receptor complex is necessary for the therapeutic responses induced by atypical and glutamate antipsychotic drugs, and is potentially involved in the altered cortical processes of schizophrenia. In order to provide a better understanding of the 5HT2A-mGlu2 complex in brain function, and the foundation for the development of more effective antipsychotic drugs, we propose to characterize the basic molecular mechanisms involved in its intracellular trafficking and signaling, as well as to investigate the antipsychotic-like behavioral responses that require expression of 5HT2A and mGlu2 as a GPCR heteromer in mouse. Our results are expected to extend our understanding of the molecular basis of psychosis, and may provide a route to the identification of new and more effective drugs for the treatment of schizophrenia and other psychiatric disorders.

描述（由申请人提供）：我们的最终目标是从机制上表征5-羟色胺5-HT2A （5HT2A）受体和代谢性谷氨酸2 （mGlu2）受体作为G蛋白偶联受体（GPCR）异聚体复合物在调节受体运输、信号传导和抗精神病样行为中的重要作用。神经递质血清素和谷氨酸都是精神病和抗精神病药物开发中相当关注的目标。家族A 5HT2A和家族C mGlu2是与精神分裂症和其他精神障碍的病理生理和治疗有关的gpcr。非典型抗精神病药物，如氯氮平、奥氮平和利培酮，都具有对5HT2A受体的高亲和力。最近在啮齿动物中的临床前试验表明，激活mGlu2受体的药物代表了潜在的新型抗精神病药物。我们之前的研究结果表明，5HT2A和mGlu2在异源系统和小鼠额叶皮层中保持密切的分子接近性。结合跨学科的方法，在体外、动物模型和死后的精神分裂症受试者的大脑中，我们提供了证据，证明5HT2A-mGlu2异源受体复合物是非典型和谷氨酸类抗精神病药物诱导的治疗反应所必需的，并且可能参与精神分裂症皮质过程的改变。为了提供